Amiodarone 30mg/ml Accord Injection
PDF Leaflet Revision Date: 07 July 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Tachydysrhythmias including atrial fibrillation and ventricular fibrillation.
Dosage (summary)
5 mg/kg IV infusion over 20 mins to 2 hours; max 1200 mg/24 hours.
Onset of Action / Duration
Onset: 15 mins, Duration: variable.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation due to risks to fetus and infant.
Key Drug Interactions
- Warfarin
- Digoxin
- Sofosbuvir
- Beta-blockers
- Calcium channel blockers
Contraindications
- Hypersensitivity to amiodarone
- Severe bradycardia
- High grade AV block
- Severe respiratory failure
Common side effects
- Bradycardia
- Hypotension
- Infusion phlebitis
Counselling Points
- Inform healthcare provider of all medications
- Monitor for signs of bradycardia
- Avoid grapefruit juice
Serious warnings
- Requires cardiac monitoring
- Risk of severe bradycardia and heart block
- Potential for pulmonary toxicity
Important Disclaimer
The Amiodarone 30mg/ml Accord Injection professional information leaflet below is the property of Accord Healthcare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
